Brand-Name Alternatives Brand-name semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are manufactured by pharmaceutical companies and distributed through traditional pharmacies, but their costs often exceed $900$1,400 per month even with insurance coverage
10.1152/ajpregu.1999.276.5.R1541 94
We do not know the long-term safety of combining these pathways
The gastroparesis or stomach paralysis lawsuits involve patients who experienced severe gastrointestinal injuries such as stomach paralysis (gastroparesis), bowel obstruction, and related complications
Recent studies have demonstrated that GLP-1 RAs exert anti-inflammatory effects, expanding their therapeutic use beyond glycemic control
We did not identify additional major safety concerns in the clinics intake, prescribing, or packaging workflow during testing